In consideration for the assets, we received from OSI $130.0 million in cash and 924,984 shares of OSI common stock.
under a manufacturing agreement with osi, we have agreed to produce for osi liposomal formulations of two products, including nx 211, at our manufacturing facility in san dimas, california.